Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced Bio Prosthetic Surfaces Ltd.

Latest From Advanced Bio Prosthetic Surfaces Ltd.

Best of the Blog START-UP February 2009

A selection of our best blog posts from February for stories not covered elsewhere in the magazine includes: Friends in High Places: The White House appears to appreciate the need for innovation and, Medtronic's $1.03 billion buying spree is only the beginning in percutaneous heart valves.

Heart Valve Market: PAVR Poised for Growth

Much like the early days of coronary stenting, percutaneous aortic valve replacement has captured the imagination of physicians and industry alike. Although many challenges remain, most physicians in the heart valve community appear optimistic that transcatheter aortic valve technologies will eventually achieve a prominent place in the treatment armamentarium, a development that would put these devices on track to achieve over $1 billion in sales within the next five years.
Medical Device

Start-Up Previews (12/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Specialty Pharmaceuticals, features profiles of Advancis Pharmaceutical Corp., Avera Pharmaceuticals Inc., ESP Pharma Inc. and Ovation Pharmaceuticals Inc. Plus these Start-Ups across Health Care: Advanced Bio Prosthetic Surfaces Ltd., Aton Pharma Inc., Kerberos Proximal Solutions Inc. and Xeotron Corp.

Advanced Bio Prosthetic Surfaces Ltd.

The future is taking shape at Advanced Bio Prosthetic Surfaces Ltd., which aims to use its proprietary nanotechnology platform to develop a new class of superior-performing, "smart" medical devices for cardiovascular and other therapeutic indications. It is leading with a covered stent for failing saphenous vein grafts.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Advanced Bio Prosthetic Surfaces Ltd.
  • Senior Management
  • Christopher E Banas, Pres. & CEO
  • Contact Info
  • Advanced Bio Prosthetic Surfaces Ltd.
    Phone: (210) 696-5300
    4778 Research Dr.
    San Antonio, TX 78240